| abstract |
The present invention defines Formula (I) {A, D, E, J, Q, R1, R2, R3, p, and j in the formula as disclosed. }, A (hetero) arylsulfonylamino-based peptidomimetic, or a pharmaceutically acceptable salt or ester thereof. Compounds represented by formula (I) have a high affinity and selectivity for somatostatin receptor subtypes sst 1 and / or sst 4, agonists or antagonists of sst 1 and / or sst 4 is useful It can be used to treat or diagnose a disease or condition that has been suggested. |